 Comparative efficacy safety bepridil diltiazem chronic stable angina pectoris refractory Bepridil Collaborative Study Group efficacy safety bepridil hydrochloride mg/day patients chronic stable angina refractory tolerated doses diltiazem median mg/day randomized multicenter double-blind parallel study Baseline diltiazem data period patients diltiazem Angina frequency nitroglycerin consumption ischemic manifestations exercise treadmill weeks Bepridil time onset time mm ST-segment depression total exercise time total work baseline values Changes time onset time mm ST-segment depression diltiazem Angina frequency nitroglycerin consumption groups baseline bepridil heart rate mean beats/min QTc mean ms frequent adverse effects groups asthenia dizziness headache diarrhea patients bepridil diltiazem withdrew study adverse reactions sudden deaths myocardial infarctions instances sustained ventricular tachycardia torsades pointes group data indicate bepridil safe effective antianginal antiischemic therapy patients chronic stable angina optimal response tolerated doses diltiazem